Atorvastatin Calcium Tablet
Product Images NDC 68788-8693

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68788-8693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 01)

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 01)
Chemical structure diagram of atorvastatin calcium showing the molecular arrangement, including the calcium ions and three water molecules associated per the hydrate form.*
FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 02)

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 02)
A line graph showing cumulative incidence (%) on the y-axis over time in years on the x-axis, comparing Atorvastatin and placebo groups. The solid line represents Atorvastatin, and the dashed line represents placebo, with Atorvastatin showing consistently lower cumulative incidence. A hazard ratio (HR=0.64) with confidence interval and p-value is noted at the bottom.*
FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 03)

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 03)
A cumulative hazard graph comparing Atorvastatin and Placebo over a five-year follow-up period. The x-axis represents time to the first primary endpoint in years, and the y-axis shows cumulative hazard percentage. Atorvastatin shows a lower cumulative hazard compared to placebo. Hazard ratio and p-value data are included, indicating statistical significance.*
FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 04)

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 04)
A Kaplan-Meier curve chart comparing the percentage of subjects experiencing a major cardiovascular event over time (years) for Atorvastatin 10 mg (dotted line) and Atorvastatin 80 mg (solid line). The x-axis is labeled 'Time to First Major Cardiovascular Endpoint (Years)' and the y-axis is labeled 'Subjects (%) Experiencing Event.' The chart includes a hazard ratio (HR) of 0.78 with confidence interval (0.69-0.89) and a P-value of 0.0002.*
FDA Label Image

Atorvastatin Calcium Tablets 20mg (3ce77d64 B08e 43b6 A3ab 3aca688f734a 06)

Atorvastatin Calcium Tablets 20mg (3ce77d64 B08e 43b6 A3ab 3aca688f734a 06)
Label for Atorvastatin Calcium Tablets 20 mg film-coated tablets, generic for Lipitor, manufactured by Graviti Pharmaceuticals Pvt. Ltd. The label includes dosage instructions in English and Spanish, storage information, and cautionary statements. It features the Preferred Pharmaceuticals Inc. logo and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.